CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Peer Education on Exercise for RecoveryWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug1003 Enhanced supervised fitness training Wiki 1.00

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D011618 Psychotic Disorders NIH 0.45
D001523 Mental Disorders NIH 0.20

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0000709 Psychosis HPO 0.45

There is one clinical trial.

Clinical Trials

1 Peer Support for Exercise in Older Veterans With Psychotic Disorders

Older adults with psychotic disorders experience a dual set of challenges: those related to serious mental illness, and those related to aging. They have medical, cognitive, psychological and social difficulties; as a result they have an almost four times greater likelihood of early institutionalization in nursing homes. These challenges make it difficult for this group to engage in health behaviors, such as exercise. This is unfortunate, since participation in health-promoting activities is essential for maintaining functional independence with age. This study aims to develop and pilot test a peer coaching intervention for older Veterans with psychotic disorders, in which VA Peer Specialists, who are Veterans in recovery from mental illness, will provide intensive coaching to older Veterans with psychotic disorders to promote their participation in exercise and physical activity. Results from this study will inform us as to whether this intervention is acceptable to Veterans, feasible to implement, and effective in increasing exercise, physical activity, and physical fitness/function.

NCT02958007 Psychotic Disorder Behavioral: Peer Education on Exercise for Recovery Behavioral: Enhanced supervised fitness training
MeSH:Mental Disorders Psychotic Disorders
HPO:Psychosis

Primary Outcomes

Description: Percent of participants randomized to PEER who attend at least three group sessions

Measure: Intervention engagement

Time: 12 weeks

Description: Percent of sampled PEER group sessions in which the peer coaches were adequately adherent (i.e., average score equal to "acceptable" and no items scored as "unacceptable") on the PEER fidelity measure

Measure: Intervention fidelity

Time: 12 weeks

Description: Attendance- mean number of supervised fitness training sessions attended

Measure: Attendance- mean number of supervised fitness training sessions attended

Time: 12 weeks

Description: Weekly step-counts will be measured by pedometer

Measure: Change from baseline in Ambulatory Physical Activity

Time: 12 weeks

Description: Maximum rate of oxygen consumption as measured during incremental exercise on a motorized treadmill

Measure: Change from baseline in Maximal Aerobic Capacity (Vo2Max)

Time: 12 weeks

Related HPO nodes (Using clinical trials)

HP:0000709: Psychosis
Genes 115
MKRN3-AS1 ALAD PDGFRB C9ORF72 SH2B1 TTC19 FCGR2B SLC25A13 CTLA4 ACADS MYORG HFE PDGFB GRN PRDM8 CACNA1A TRNF SOBP UPF3B GSS ALDH5A1 SNRPN PWAR1 STAT4 TBC1D7 ZFYVE26 MECP2 CBS EPM2A MED12 ATP13A2 ND1 ND4 PDGFB USP8 SLC6A19 CDH23 VPS13A COX1 SPART SQSTM1 TWNK ITM2B TRNW NPAP1 MKRN3 TRNQ DNMT1 ND5 PRKAR1A ABCD1 GCLC SLC7A7 IRAK1 PRNP CLN8 ND6 PCDH19 PPOX NPC2 SLC12A6 SNORD116-1 PARK7 ATXN7 MAPT SLC20A2 PAK3 NDP COX3 HMBS KCNT1 WFS1 DNASE1 AIP TMEM106B ALDH18A1 PCDH19 PWRN1 PSEN1 NDN COX2 C9ORF72 RPS6KA3 PDE11A TRNS2 WFS1 TREM2 NDP CHMP2B PUS3 PTPN22 SPP1 IPW DCAF17 DCAF17 LMBRD1 HERC2 ZDHHC9 TREX1 CLN3 NHLRC1 TRNS1 MAGEL2 PANK2 GNAS TRNL1 FCGR2A TRNH VCP NAGS USP8 SNORD115-1 NPC1 MED12 PAH
Protein Mutations 6
D61804R N40D S311C S9G V158M V66M
SNP 4
rs1006737 rs1799732 rs3813929 rs6971